Named as a key player in 50 of our reports, across 50 regions and countries.
Our reports that name Inotiv as a key player, by category and place.
Markets where they are a key player. Each opens the market's statistics for every place we cover.
None of their markets match.
Our newest markets with them as a key player. Each covers 2024 history, a 2025 base year and forecasts to 2034.
Named as key players in the same markets as Inotiv (number of shared markets).
Charles River Laboratories5 shared markets
Eurofins Scientific3 shared markets
Labcorp3 shared markets
The Jackson Laboratory2 shared markets
WuXi AppTec2 shared markets
Catalent1 shared market
Champions Oncology1 shared market
Crown Bioscience1 shared market
The topics of the markets Inotiv is in.
Stories on the topics Inotiv works in.
Sequencing a human genome fell from about $50 million in 2003 to under $1,500 by late 2015. Bioinformatics…
Read
In September 2024 the FDA finalised guidance on trials with decentralised elements, such as telehealth…
Read
Phones and wearables can measure how people walk, talk, sleep and move. These digital biomarkers are starting…
Read